Every public signal F4 has attached to this firm, with sources and cross-entity links.
Mariana Oncology
Rectify Pharma
Numab Therapeutics appoints Dr. Rajesh Chopra as Chief Scientific Officer
VectorY
Mosanna Therapeutics
Corsera Health named a 2026 Endpoints 11 honoree
RQ Bio
Altesa BioSciences
Growth Opportunities Fund III (€1.2bn) and Ventures Fund VII (€890m)